Filing Details
- Accession Number:
- 0001209191-17-003660
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-13 16:12:22
- Reporting Period:
- 2017-01-11
- Filing Date:
- 2017-01-13
- Accepted Time:
- 2017-01-13 16:12:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-11 | 8,000 | $36.30 | 276,225 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-11 | 2,400 | $81.25 | 273,825 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-11 | 2,900 | $82.17 | 270,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-11 | 1,100 | $82.92 | 269,825 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-11 | 1,100 | $84.41 | 268,725 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-11 | 500 | $84.98 | 268,225 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-11 | 8,000 | $0.00 | 8,000 | $36.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-01-23 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 13,286 | Indirect | 401(k) |
| Common Stock | 78,200 | Indirect | Common Stock Held In Trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $81.25 (range $80.61 to $81.60).
- Open market sales reported on this line occurred at a weighted average price of $82.17 (range $81.62 to $82.55).
- Open market sales reported on this line occurred at a weighted average price of $82.92 (range $82.64 to $83.24).
- Open market sales reported on this line occurred at a weighted average price of $84.41 (range $83.72 to $84.70).
- Open market sales reported on this line occurred at a weighted average price of $84.98 (range $84.87 to $85.11).
- Fully vested.
Billionaire Hedge Funds
